Cataract Removal Clinical Trials

Clinical trials related to Cataract Removal Procedure

The Use of Sublingual Melatonin Premedication in Geriatric Cataract Surgery

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

Cataract surgery is routinely performed with anesthesia care, whereas anesthesia care for other elective, low-risk, outpatient procedures is applied more selectively. We hypothesize that sublingual melatonin will provide superior anxiolysis and sedation while maintaining a high safety profile and minimizing hemodynamic disturbances.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 60
Healthy Volunteers: f
View:

• • Age ≥ 60 years

‣ American Society of Anesthesiologists (ASA) physical status I-III

⁃ Scheduled for unilateral cataract surgery under local anesthesia

⁃ Ability to understand and complete study-related questionnaires

Locations
Other Locations
Egypt
Al-Azhar University
NOT_YET_RECRUITING
Cairo
Iraq
Al-Azhar University
RECRUITING
Baghdad
Contact Information
Primary
Neveen A Kohaf, PhD
nevenabdo@azhar.edu.eg
+201060383012
Time Frame
Start Date: 2025-09-01
Estimated Completion Date: 2026-06-15
Participants
Target number of participants: 60
Treatments
Active_comparator: Melatonin Group
a 6 mg sublingual tablet of melatonin will be administered for all patients at 60 minutes before surgery.
Placebo_comparator: Placebo Group
the participants will be received a visually identical tablet containing inert ingredients at 60 minutes before surgery.
Related Therapeutic Areas
Sponsors
Leads: Al-Azhar University

This content was sourced from clinicaltrials.gov